Alcohol Use Disorder Clinical Trials in Boston, Massachusetts

5 studies are recruiting for alcohol use disorder in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

   The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use Disorder (AUD). Participation in this study will last approximately 56 weeks.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Adams Clinical Boston, Boston, Massachusetts

   Locations

   118 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219966 on ClinicalTrials.gov

2. A Study of Brenipatide in Participants With Alcohol Use Disorder

   The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and hazardous alcohol use. Participation in this study will last approximately 56 weeks.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Adams Clinical Boston, Boston, Massachusetts

   Locations

   116 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219953 on ClinicalTrials.gov

3. Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

   "Gold-standard" medications for opioid use disorder (MOUD) treatment combines FDA-approved medications, primarily methadone and buprenorphine, with behavioral therapies to provide "whole-patient" treatment. Prior to the pandemic, methadone and buprenorphine were subject to greater federal regulatio…

   Stage

   Not phased

   Ages

   18 and older

   Site

   VA Medical Center, Boston, Massachusetts

   Run by

   Boston University

   See if you can join NCT07232641 on ClinicalTrials.gov

4. Impulsivity Domains and Subjective Response

   Findings from this project will determine the relationship between two vulnerability factors for Alcohol Use Disorder (AUD) in young adults: impulsivity and subjective response to alcohol. The results will identify badly needed, novel targets for prevention and treatment efforts to simultaneously r…

   Stage

   EARLY_Phase 1

   Ages

   21 to 25

   Site

   Northeastern University, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Jessica Weafer

   See if you can join NCT05929677 on ClinicalTrials.gov

5. Integrated Treatment for Enhancing Growth in Recovery During Adolescence

   This is a Phase II parallel group randomized controlled trial with 294 adolescents (age: 14-21 years) with alcohol and other drug [AOD] use disorder (hereafter substance use disorder), that compares two different active psychosocial interventions designed to address adolescent substance use disorde…

   Stage

   Not phased

   Ages

   14 to 21

   Site

   MGH Department of Psychiatry, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT06395467 on ClinicalTrials.gov